Weight- and Health-Related Quality of Life (WRQoL and HRQoL) with Canagliflozin (CANA) Versus Sitagliptin (SITA) in Subjects with Type 2 Diabetes Mellitus (T2DM) on Background Metformin
03 medical and health sciences
0302 clinical medicine
Health Policy
Public Health, Environmental and Occupational Health
DOI:
10.1016/j.jval.2013.08.716
Publication Date:
2013-10-22T03:54:04Z
AUTHORS (2)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....